These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31229835)

  • 21. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice.
    Gonzalez L; Qian AS; Tahir U; Yu P; Trigatti BL
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages.
    Wang Y; Wang GZ; Rabinovitch PS; Tabas I
    Circ Res; 2014 Jan; 114(3):421-33. PubMed ID: 24297735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
    Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice.
    Qiao M; Kisgati M; Cholewa JM; Zhu W; Smart EJ; Sulistio MS; Asmis R
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1375-82. PubMed ID: 17363688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
    Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
    Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
    Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
    Yu P; Qian AS; Chathely KM; Trigatti BL
    Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
    Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIF-1α (Hypoxia-Inducible Factor-1α) Promotes Macrophage Necroptosis by Regulating miR-210 and miR-383.
    Karshovska E; Wei Y; Subramanian P; Mohibullah R; Geißler C; Baatsch I; Popal A; Corbalán Campos J; Exner N; Schober A
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):583-596. PubMed ID: 31996026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
    Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
    Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism involving NADPH oxidase down-regulation in endothelial cells.
    Aguilar EC; Santos LC; Leonel AJ; de Oliveira JS; Santos EA; Navia-Pelaez JM; da Silva JF; Mendes BP; Capettini LS; Teixeira LG; Lemos VS; Alvarez-Leite JI
    J Nutr Biochem; 2016 Aug; 34():99-105. PubMed ID: 27261536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LOX‑1 is implicated in oxidized low‑density lipoprotein‑induced oxidative stress of macrophages in atherosclerosis.
    Yang HY; Bian YF; Zhang HP; Gao F; Xiao CS; Liang B; Li J; Zhang NN; Yang ZM
    Mol Med Rep; 2015 Oct; 12(4):5335-41. PubMed ID: 26165515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR; Moulton KS; Kazlauskas A
    Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial Oxidative Stress Promotes Atherosclerosis and Neutrophil Extracellular Traps in Aged Mice.
    Wang Y; Wang W; Wang N; Tall AR; Tabas I
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):e99-e107. PubMed ID: 28596373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages.
    Lara-Guzmán OJ; Gil-Izquierdo Á; Medina S; Osorio E; Álvarez-Quintero R; Zuluaga N; Oger C; Galano JM; Durand T; Muñoz-Durango K
    Redox Biol; 2018 May; 15():1-11. PubMed ID: 29195136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.